Company: CERO
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112619
Chunk: 284

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 8
Chunk 284
---

    2024-09-25

    0001870404
    
      us-gaap:InvestorMember

    2025-03-10

    0001870404
    
      us-gaap:SeriesCPreferredStockMember

    2025-03-10

    0001870404
    
      us-gaap:SeriesCPreferredStockMember

    2025-03-10
    2025-03-10

    0001870404
    
      us-gaap:SeriesBPreferredStockMember
      us-gaap:CommonStockMember

    2025-04-01
    2025-06-30

    0001870404
    
      us-gaap:SeriesBPreferredStockMember

    2025-04-01
    2025-06-30

    0001870404
    
      srt:MinimumMember

    2025-06-30

    0001870404
    
      srt:MaximumMember

    2025-06-30

    0001870404
    
      us-gaap:SeriesBPreferredStockMember

    2025-06-30

    0001870404
    
      srt:MaximumMember
      us-gaap:SeriesCPreferredStockMember

    2025-06-30

    0001870404
    
      srt:MinimumMember
      us-gaap:SeriesCPreferredStockMember

    2025-06-30

    0001870404
    
      us-gaap:SeriesCPreferredStockMember
      us-gaap:CommonStockMember

    2025-07-18

    0001870404
    
      us-gaap:SeriesCPreferredStockMember

    2025-07-18

    0001870404
    
      us-gaap:SeriesCPreferredStockMember
      us-gaap:PreferredStockMember

    2025-07-18

    0001870404
    
      us-gaap:SeriesAPreferredStockMember
      us-gaap:PreferredStockMember

    2025-09-30

    0001870404
    
      us-gaap:SeriesDPreferredStockMember

    2025-04-22

    0001870404
    
      us-gaap